Robert Thomas Dechant - 16 Sep 2025 Form 4/A - Amendment Insider Report for IBEX Ltd (IBEX)

Role
Chief Executive Officer, Director
Signature
Lisa Lenstrohm, Attorney-in-Fact
Issuer symbol
IBEX
Transactions as of
16 Sep 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
13 Nov 2025, 17:10:54 UTC
Date Of Original Report
17 Sep 2025
Previous filing
15 Sep 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dechant Robert Thomas Chief Executive Officer, Director C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON Lisa Lenstrohm, Attorney-in-Fact 13 Nov 2025 0001298255

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBEX Stock Option (Right to Buy Common Shares) Options Exercise $0 -45,027 -100% $0.000000 0 16 Sep 2025 Common Shares 45,027 $19.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition and sale of the common shares underlying these options was previously reported on Form 4 on September 17, 2025. The exercise of the options was inadvertently not included in that Form 4 filing, so is now reported in this Amendment.
F2 The shares subject to this option are fully vested and exercisable.